CompletedPhase 2NCT02432768

The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)

Studying Disorder of carbohydrate metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rigshospitalet, Denmark
Principal Investigator
Karen L Madsen, MD
Neuromuscular Research Unit, Rigshospitalet
Intervention
Triheptanoin(drug)
Enrollment
22 enrolled
Eligibility
18-65 years · All sexes
Timeline
20152019

Study locations (1)

Collaborators

Groupe Hospitalier Pitie-Salpetriere · University of Texas Southwestern Medical Center · Ultragenyx Pharmaceutical Inc

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02432768 on ClinicalTrials.gov

Other trials for Disorder of carbohydrate metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of carbohydrate metabolism

← Back to all trials